Marriaga NB, López LP, Solórzano SF, Arellano-Valdez CA, Pacheco-Quintanares L, González Novoa DM

Language: Spanish
References: 25
Page: 128-131
PDF size: 173.66 Kb.

ABSTRACT

Behçet’s disease is a systemic inflammatory disease, classically manifested by the triad of oral thrush, genital ulcers and uveitis. The ocular, neurological and vascular involvement determine the prognosis of the disease. Clinical manifestations and the lack of diagnostic tests make Behçet’s disease a diagnostic challenge. In Mexico its prevalence is unknown. The case of a 10-year-old female patient with viral pharyngeal symptoms, pain and ulcers in the genital area is presented; the absence of other symptoms, its low prevalence and high clinical heterogeneity representing a diagnostic challenge.

REFERENCES

1. Matteson, E.L., “Notes on the history of eponymic idiopathicvasculitis: the diseases of Henoch and Schönlein,Wegener, Churg and Strauss, Horton, Takayasu, Behçet,and Kawasaki”, Arthritis Care Res, 2000, 13 (4): 237-245.

2. Calzada-Hernández, J., “Enfermedad de Behçet”, ProtocDiagn Ter Pediatr, 2020, 2: 201-212.

3. Jennette, J.C., Falk, R.J., Bacon, P.A., Basu, N., Cid, M.C.,Ferrario, F. et al., “2012 revised International Chapel HillConsensus Conference Nomenclature of Vasculitides”,Arthritis Rheum, 2013, 65 (1): 1-11.

4. Ozen, S., Ruperto, N., Dillon, M.J., Bagga, A., Barron,K., Davin, J.C. et al., “eular/pres endorsed consensuscriteria for the classification of childhood vasculitides”,Ann Rheum Dis, 2006, 65 (7): 936-941.

5. Koné-Paut, I., Shahram, F., Darce-Bello, M., Cantarini, L.,Cimaz, R., Gattorno, M. et al., “pedbd Group. Consensusclassification criteria for paediatric Behçet’s diseasefrom a prospective observational cohort: pedbd”, AnnRheum Dis, 2016, 75 (6): 958-964.

6. Bang, D., Lee, J.H., Lee, E.S., Lee, S., Choi, J.S., Kim,Y.K. et al., “Epidemiologic and clinical survey of Behcet’sdisease in Korea: the first multicenter study”, JKorean Med Sci, 2001, 16 (5): 615-618.

7. Karincaoglu, Y., Borlu, M., Toker, S.C., Akman, A., Onder,M., Gunasti, S. et al., “Demographic and clinical propertiesof juvenile-onset Behçet's disease: a controlledmulticenter study”, J Am Acad Dermatol, 2008, 58 (4):579-584.

8. Kaneko, F., Oyama, N. y Nishibu, A., “Streptococcal infectionin the pathogenesis of Behçet’s disease and clinicaleffects of minocycline on the disease symptoms”,Yonsei Med J, 1997, 38 (6): 444-454.

9. Baskan, E.B., Yilmaz, E., Saricaoglu, H., Alkan, G., Ercan,I., Mistik, R., Adim, S.B., Goral, G., Dilek, K. y Tunali, S.,“Detection of parvovirus b19 dna in the lesional skinof patients with Behçet’s disease”, Clin Exp Dermatol,2007, 32 (2): 186-190.

10. Ersoy, O., Ersoy, R., Yayar, O., Demirci, H. y Tatlican, S.,“H pylori infection in patients with Behcet’s disease”,World J Gastroenterol, 2007, 13 (21): 2983-2985.

11. Gündüz, O., “Histopathological evaluation of Behçet’sdisease and identification of new skin lesions”, PathologRes Int, 2012, 2012: 209316.

12. De Menthon, M., Lavalley, M.P., Maldini, C., Guillevin, L.y Mahr, A., “hla-b51/b5 and the risk of Behçet’s disease:a systematic review and meta-analysis of case-controlgenetic association studies”, Arthritis Rheum, 2009, 61(10): 1287-1296.

13. Hatemi, G., Seyahi, E., Fresko, I., Talarico, R., Uçar, D. yHamuryudan, V., “Behçet’s syndrome: one year in review2022”, Clin Exp Rheumatol, 2022, 40: 1461-1471.

14. Koné-Paut, I., “Behçet’s disease in children, an overview”,Pediatr Rheumatol Online J, 2016, 14 (1): 10.

15. Faezi, S.T., Paragomi, P., Shahram, F., Shams, H., Shams-Davatchi, C., Ghodsi, Z. et al., “Clinical features ofBehcet’s disease in patients without oral aphthosis”,Mod Rheumatol, 2014, 24 (4): 637-639.

16. López-García, S., Vizán-Caravaca, J.R. y García-Castro,J.M., “Síndrome de Behçet”, Aten Primaria, 2020, 52(4): 275-276.

17. Ideguchi, H., Suda, A., Takeno, M., Ueda, A., Ohno, S.e Ishigatsubo, Y., “Behçet disease: evolution of clinicalmanifestations”, Medicine (Baltimore), 2011, 90 (2):125-132.

18. International Study Group for Behçet’s Disease, “Criteriafor diagnosis of Behçet’s disease”, Lancet, 1990,335 (8697): 1078-1080.

19. Shahram, F., Assadi, K., Davatchi, F., Nadji, A., Jamshidi,A., Chams, C. y Akbarian, M., “Chronology of clinicalmanifestations in Behçet’s disease. Analysis of 4 024cases”, Adv Exp Med Biol, 2003, 528: 85-89.

20. Davatchi, F., Shahram, F., Chams-Davatchi, C., Shams,H., Nadji, A., Akhlaghi, M. et al., “Behcet’s disease inIran: analysis of 6 500 cases”, Int J Rheum Dis, 2010,13 (4): 367-373.

21. Karincaoglu, Y., Borlu, M., Toker, S.C., Akman, A., Onder,M., Gunasti, S. et al., “Demographic and clinical propertiesof juvenile-onset Behçet’s disease: a controlledmulticenter study”, J Am Acad Dermatol, 2008, 58 (4):579-584.

22. Kalra, S., Silman, A., Akman-Demir, G., Bohlega, S.,Borhani-Haghighi, A., Constantinescu, C.S. et al., “Diagnosisand management of neuro-Behçet’s disease:international consensus recommendations”, J Neurol,2014, 261 (9): 1662-1676.

23. Batu, E.D., “Diagnostic/classification criteria in pediatricBehçet’s disease”, Rheumatol Int, 2019, 39 (1): 37-46.doi: 10.1007/s00296-018-4208-9.

24. Sota, J., Rigante, D., Lopalco, G. et al., “Clinical profileand evolution of patients with juvenile-onset Behçet'ssyndrome over a 25-year period: insights from the aidanetwork”, Intern Emerg Med, 2021, 16 (8): 2163-2171.

25. Yildiz, M., Haslak, F., Adrovic, A., Sahin, S., Koker, O.,Barut, K., Kasapcopur, O., “Pediatric Behçet’s disease”,Front Med (Lausana), 2021, 8: 627192.5.